ClinicalTrials.Veeva

Menu

Effect of β-alanine Supplementation on Muscle Carnosine (LitmusMagnet)

N

Nestlé

Status

Completed

Conditions

Healthy

Treatments

Dietary Supplement: beta-alanine
Dietary Supplement: placebo

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT00813553
08.13.PER

Details and patient eligibility

About

Carnosine is a natural acid buffering substance of muscle. The primary objective of this study is to test whether a nutritional supplement of beta-alanine enhances carnosine content in muscle.

Full description

Volunteers will be randomized to receiving 3 nutritional supplements. Two supplements contain beta-alanine at different doses, the third supplement is a placebo.

Enrollment

30 estimated patients

Sex

Male

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Stable health as evaluated by medical evaluation
  • Body mass index higher than 18 kg/m2
  • Body mass index lower than 25 kg/m2, unless body fat is less than 20%

Exclusion criteria

  • intolerance to β-alanine,
  • allergy to soy, fish and crustacean
  • participation in another intervention study
  • consumer of dietary supplement susceptible to contain beta-alanine
  • determined to have very high baseline muscle carnosine concentration

Trial design

30 participants in 3 patient groups, including a placebo group

beta-alanine 0
Placebo Comparator group
Treatment:
Dietary Supplement: placebo
beta-alanine 1
Experimental group
Treatment:
Dietary Supplement: beta-alanine
Dietary Supplement: beta-alanine
beta-alanine 2
Experimental group
Treatment:
Dietary Supplement: beta-alanine
Dietary Supplement: beta-alanine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems